Clinical Research Directory
Browse clinical research sites, groups, and studies.
Non-invasive Vagal Neurostimulation (nVNS) for Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Summary
This is a prospective, randomized, two-arm, controlled 30-day investigational pilot trial using the gammaCore Sapphire S non-invasive vagus nerve stimulation (nVNS) device + standard of care (SOC) in newly-hospitalized patients with mild-to-moderate traumatic brain injury (TBI) to prevent the progression towards immunokine storms, systemic inflammatory response syndrome (SIRS), severe respiratory distress, and requirement for invasive mechanical ventilation, and death, when compared to SOC alone (the control arm).
Official title: Non-invasive Vagal Neurostimulation (nVNS) to Mitigate Traumatic Brain Injury (TBI)-Induced Acute Respiratory Distress and Acute Lung Injury
Key Details
Gender
All
Age Range
12 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
3
Start Date
2021-08-04
Completion Date
2025-03-01
Last Updated
2026-05-29
Healthy Volunteers
No
Conditions
Interventions
nVNS
3x daily treatment of nVNS + SOC
SOC
Standard of care patient management.
Locations (1)
AHN Allegheny General Hospital
Pittsburgh, Pennsylvania, United States